back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-25 09:13 Tx date 2024-09-24 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,428 vol |
5,405 | |
| Filed 2024-06-25 17:29 Tx date 2024-06-25 |
$MDA
MDA Space Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,090 vol |
2,977 | |
| Filed 2024-04-02 10:10 Tx date 2024-03-31 |
$MDA
MDA Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+887 vol |
887 | |
| Filed 2024-04-02 10:09 Tx date 2024-02-14 |
$MDA
MDA Ltd. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-13 16:04 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,267
+13,334 vol $1.07 each |
333,334 | |
| Filed 2024-01-13 16:03 Tx date 2024-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-14,267.38
-13,334 vol $1.07 each |
1,666 | |
| Filed 2023-11-18 15:20 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,733
+1,667 vol $1.04 each |
320,000 | |
| Filed 2023-11-18 15:19 Tx date 2023-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-1,733.68
-1,667 vol $1.04 each |
15,000 | |
| Filed 2023-09-15 18:24 Tx date 2023-09-12 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
40,000 | |
| Filed 2023-01-14 15:54 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$7,866
+13,333 vol $0.59 each |
318,333 | |
| Filed 2023-01-14 15:53 Tx date 2023-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-7,866.47
-13,333 vol $0.59 each |
16,667 | |
| Filed 2022-12-01 22:19 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,560
+5,334 vol $0.48 each |
305,000 | |
| Filed 2022-12-01 22:18 Tx date 2022-11-28 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-2,560.32
-5,334 vol $0.48 each |
30,000 | |
| Filed 2022-11-19 12:58 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$800.16
+1,667 vol $0.48 each |
299,666 | |
| Filed 2022-11-19 12:57 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-800.16
-1,667 vol $0.48 each |
35,334 | |
| Filed 2022-11-19 12:55 Tx date 2022-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
25,000 | |
| Filed 2022-01-13 13:56 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+13,333 vol |
297,999 | |
| Filed 2022-01-13 13:53 Tx date 2022-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-13,333 vol |
37,001 | |
| Filed 2021-12-01 23:39 Tx date 2021-11-29 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+5,333 vol |
284,666 | |
| Filed 2021-12-01 23:38 Tx date 2021-11-29 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,333 vol |
50,334 | |
| Filed 2021-11-19 20:24 Tx date 2021-11-15 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,000 vol |
55,667 | |
| Filed 2021-11-03 16:59 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,265
+23,500 vol $0.99 each |
279,333 | |
| Filed 2021-11-03 16:58 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,430
+3,500 vol $0.98 each |
255,833 | |
| Filed 2021-11-03 16:58 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$960.00
+1,000 vol $0.96 each |
252,333 | |
| Filed 2021-11-03 16:57 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,175
+6,500 vol $0.95 each |
251,333 | |
| Filed 2021-11-03 16:56 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,740
+21,000 vol $0.94 each |
244,833 | |
| Filed 2021-11-03 16:55 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,650
+5,000 vol $0.93 each |
223,833 | |
| Filed 2021-11-03 16:55 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,275
+2,500 vol $0.91 each |
218,833 | |
| Filed 2021-11-03 16:54 Tx date 2021-11-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,250
+25,000 vol $0.89 each |
216,333 | |
| Filed 2021-10-13 17:19 Tx date 2021-10-04 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+12,000 vol |
191,333 | |
| Filed 2021-10-13 17:18 Tx date 2021-10-04 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-12,000 vol |
50,667 | |
| Filed 2021-01-15 19:01 Tx date 2021-01-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+40,000 vol |
62,667 | |
| Filed 2020-12-17 18:50 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
37 - Stock split or consolidation
|
-204,000 vol |
22,667 | |
| Filed 2020-12-17 18:49 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-180,000 vol |
20,000 | |
| Filed 2020-12-17 18:48 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-2,160,000 vol |
240,000 | |
| Filed 2020-12-17 18:47 Tx date 2020-12-01 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,614,000 vol |
179,333 | |
| Filed 2020-12-17 14:50 Tx date 2020-11-30 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+53,333 vol |
1,793,333 | |
| Filed 2020-12-17 14:49 Tx date 2020-11-30 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-53,333 vol |
226,667 | |
| Filed 2020-10-08 22:45 Tx date 2020-10-05 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+120,000 vol |
1,740,000 | |
| Filed 2020-10-08 22:43 Tx date 2020-10-05 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-120,000 vol |
280,000 | |
| Filed 2020-06-06 14:41 Tx date 2020-06-05 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$75,000
+500,000 vol $0.15 each |
2,400,000 | |
| Filed 2020-06-06 14:40 Tx date 2020-06-05 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-75,000
-500,000 vol $0.15 each |
0 | |
| Filed 2019-11-28 13:16 Tx date 2019-11-28 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+160,000 vol |
400,000 | |
| Filed 2019-10-10 16:06 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+120,000 vol |
1,620,000 | |
| Filed 2019-10-10 16:05 Tx date 2019-10-03 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-120,000 vol |
240,000 | |
| Filed 2018-12-13 Tx date 2018-12-13 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$66,000
+300,000 vol $0.22 each |
1,900,000 | |
| Filed 2018-12-13 Tx date 2018-12-13 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-66,000
-300,000 vol $0.22 each |
500,000 | |
| Filed 2018-10-05 Tx date 2018-10-03 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
97 - Other
|
+360,000 vol |
360,000 | |
| Filed 2018-10-05 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-10 Tx date 2018-06-05 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-75,000
-500,000 vol $0.15 each |
0 | |
| Filed 2018-06-10 Tx date 2018-06-05 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$75,000
+500,000 vol $0.15 each |
1,500,000 | |
| Filed 2017-09-12 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-12 Tx date 2017-09-08 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
-1,000,000 vol |
0 | |
| Filed 2017-09-12 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-12 Tx date 2017-09-08 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
+1,000,000 vol |
1,000,000 | |
| Filed 2017-09-12 Tx date 2017-09-08 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
|
Warrants
90 - Change in the nature of ownership
|
-500,000 vol |
0 | |
| Filed 2017-09-12 Tx date 2017-09-08 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Warrants
90 - Change in the nature of ownership
|
+500,000 vol |
500,000 | |
| Filed 2017-08-21 Tx date 2017-08-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$50,000
+500,000 vol $0.10 each |
800,000 | |
| Filed 2017-08-21 Tx date 2017-08-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+1,000,000 vol $0.10 each |
1,600,000 | |
| Filed 2017-07-19 Tx date 2017-07-11 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+600,000 vol |
600,000 | |
| Filed 2017-07-19 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-19 Tx date 2017-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Warrants
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+300,000 vol |
300,000 | |
| Filed 2017-07-19 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: NFQ Ventures Ltd (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-03 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-03 Tx date 2017-03-31 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+200,000 vol $0.20 each |
200,000 | |
| Filed 2016-07-21 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2016-07-21 Tx date 2016-07-18 |
$ATE
Antibe Therapeutics Inc. |
Wu, Yung Cheng
4 - Director of Issuer
Holder: Raging Boar Enterprises (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,000,000 |